Optimal timing of percutaneous coronary intervention in elderly patients with acute ST-segment elevation myocardial infarction presenting late

被引:0
|
作者
Jia, Haiyan [1 ,2 ]
Zhang, Weifeng [1 ,2 ]
Jia, Shengqi [3 ]
Zhang, Jun [2 ]
Xu, Zhanwen [1 ]
Li, Yaqin [1 ]
机构
[1] Hebei Univ, Affiliated Hosp, Dept Cardiol, Baoding, Peoples R China
[2] Tianjin Med Univ, Cangzhou Cent Hosp, Dept Cardiol, Tianjin, Peoples R China
[3] Hebei Med Univ, Hosp 2, Dept Cardiol, Shijiazhuang, Peoples R China
关键词
acute ST segment elevated myocardial infarction; different timing of percutaneous coronary intervention; cardiac mortality; heart failure-related rehospitalization; THROMBUS COMPOSITION; SPONTANEOUS REPERFUSION; MECHANICAL REPERFUSION; CLINICAL-OUTCOMES; INVASIVE STRATEGY; METAANALYSIS; ANGIOPLASTY; ASPIRATION; IMMEDIATE; OCCLUSION;
D O I
10.5114/kitp.2024.143685
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Primary percutaneous coronary intervention (PPCI) is an effective method for the clinical treatment of acute ST-segment elevation myocardial infarction (STEMI). For patients who miss the optimal time window, optimal management of these patients remains controversial. Aim: To compare the effects of different timing of percutaneous coronary intervention on the long-term prognosis of elderly patients with acute ST-segment elevation myocardial infarction (STEMI) with time from symptom onset > 12 hours. Material and methods: Elderly acute STEMI patients with time from symptom onset > 12 hours in the period from July 2021 to July 2022 in the Department of Cardiology, Affiliated Hospital of Hebei University, were randomly divided into four groups: group 1 (immediate invasive strategy, percutaneous coronary interventions (PCI) < 24 hours after symptoms onset, n = 80), group 2 (early invasive strategy, 24-< 72 hours after symptoms onset, n = 80), group 3 (delayed invasive strategy after symptoms onset, 72-< 168 hours after symptoms onset, n = 80), and group 4 (late PCI group after symptoms onset, >= 168 hours after symptoms onset, n = 80). Primary study end points were 12-month cardiac mortality, nonfatal myocardial infarction (MI), target-vessel revascularization, and heart failure-related rehospitalization. Results: There were no significant differences between groups in cardiac mortality, nonfatal MI and target-vessel revascularization. During follow-up, heart failure-related rehospitalization was higher in group 1 than in the other groups (18.8% vs. 5.1% vs. 7.4% vs. 6.3%, p = 0.010). Compared with group 1, group 2, group 3 and group 4 had lower heart failure-related rehospitalization (HR = 0.250, Conclusions: For acute STEMI patients who missed the optimal time of PCI, immediate PCI did not reduce adverse clinical outcomes.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 50 条
  • [31] Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention
    Y. L. Gu
    T. Svilaas
    I. C. C. van der Horst
    F. Zijlstra
    Netherlands Heart Journal, 2008, 16 : 325 - 331
  • [32] Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention
    Gu, Y. L.
    Svilaas, T.
    van der Horst, I. C. C.
    Zijistra, F.
    NETHERLANDS HEART JOURNAL, 2008, 16 (10) : 325 - 331
  • [33] Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Jacobs, Joshua A.
    Pickworth, Kerry
    Boudoulas, Konstantinos Dean
    Hinkley, Megan
    McLaughlin, Eric
    Blais, Danielle
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (08) : 711 - 715
  • [34] Results of the Croatian Primary Percutaneous Coronary Intervention Network for Patients With ST-Segment Elevation Acute Myocardial Infarction
    Heitzler, Vjeran Nikolic
    Babic, Zdravko
    Milicic, Davor
    Bergovec, Mijo
    Raguz, Miroslav
    Mirat, Jure
    Strozzi, Maja
    Plazonic, Zeljko
    Giunio, Lovel
    Steiner, Robert
    Starcevic, Boris
    Vukovic, Ivica
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09): : 1261 - 1267
  • [35] Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Yan, Yan
    Gong, Wei
    Ma, Changsheng
    Wang, Xiao
    Smith, Sidney C., Jr.
    Fonarow, Gregg C.
    Morgan, Louise
    Liu, Jing
    Vicaut, Eric
    Zhao, Dong
    Montalescot, Gilles
    Nie, Shaoping
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) : 251 - 263
  • [36] Predictive factors predicting inadequate ST-segment resolution in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention
    刘晓宇
    China Medical Abstracts(Internal Medicine), 2014, 31 (03) : 158 - 159
  • [37] Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction
    Sudhakar, Deepthi
    Jneid, Hani
    Lakkis, Nasser
    Kayani, Waleed T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 134 : 158 - 158
  • [38] Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction
    Savage, Michael L.
    Hay, Karen
    Murdoch, Dale J.
    Walters, Darren L.
    Denman, Russell
    Ranasinghe, Isuru
    Raffel, Christopher
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 100 (04) : 520 - 529
  • [39] Management of acute myocardial infarction in patients presenting with ST-segment elevation
    Van de Werf, F
    Ardissino, D
    Betriu, A
    Cokkinos, DV
    Falk, E
    Fox, KAA
    Julian, D
    Lengyel, M
    Neumann, FJ
    Ruzyllo, W
    Thygesen, C
    Underwood, SR
    Vahanian, A
    Verheugt, FWA
    Wijns, W
    EUROPEAN HEART JOURNAL, 2003, 24 (01) : 28 - 66
  • [40] TICAGRELOR FOR PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AFTER EMERGENCY PERCUTANEOUS CORONARY INTERVENTION
    Han, L.
    Zhang, J. J.
    Jing, H. F.
    Qin, L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 485 - 490